Pelvic examination findings and chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test

Sexually Transmitted Diseases

Volumn 34, Issue 6, 2007, Pages 335-338

  Geisler, William M ^a   Chow, Joan M ^b   Schachter, Julius ^b   Mccormack, William M ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADNEXA DISEASE; ADOLESCENT; ADULT; ARTICLE; BLEEDING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MULTIVARIATE ANALYSIS; NUCLEIC ACID AMPLIFICATION; PELVIS; PUS; RETROSPECTIVE STUDY; SCREENING TEST; UTERINE CERVIX; UTERINE CERVIX DISEASE; UTERINE CERVIX ECTOPIA; UTERINE CERVIX MUCOPUS; VAGINA DISCHARGE;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; FEMALE; HUMANS; MASS SCREENING; NEW YORK CITY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SAN FRANCISCO; VAGINAL SMEARS;

EID: 34249332775     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000240344.20665.63     Document Type: Article

References (16)

1. Stamm WE. Chlamydia trachomatis - The persistent pathogen: Thomas Parran Award Lecture. Sex Transm Dis 2001; 28:684-689.
2. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis - The ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
3. Lindner LE, Geerling S, Nettum JA, et al. Clinical characteristics of women with chlamydial cervicitis. J Reprod Med 1988; 33:684-690.
4. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534-543.
5. Paavonen J, Critchlow CW, DeRouen T, et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986; 154:556-564.
6. Paavonen J, Vesterinen E. Chlamydia trachomatis in cervicitis and urethritis in women. Scand J Infect Dis Suppl 1982; 32:45-54.
7. Paavonen J, Stevens CE, Wolner-Hanssen P, et al. Colposcopic manifestations of cervical and vaginal infections. Obstet Gynecol Surv 1988; 43:373-381.
8. Harrison HR, Costin M, Meder JB, et al. Cervical Chlamydia trachomatis infection in university women: Relationship to history, contraception, ectopy, and cervicitis. Am J Obstet Gynecol 1985; 153:244-251.
9. Marrazzo JM, Johnson RE, Green TA, et al. Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for Chlamydia trachomatis genital infection in women. J Clin Microbiol 2005; 43:577-584.
10. Schachter J, McCormack WM, Chernesky MA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003; 41:3784-3789.
11. Geisler WM, Suchland RJ, Whittington WLH, Stamm WE. Quantitative culture of Chlamydia trachomatis: Correlation of inclusionforming units produced in culture with clinical manifestations of urogenital disease. J Infect Dis 2001; 184:1350-1354.
12. Serlin M, Shafer M, Tebb K, et al. What sexually transmitted screening method does the adolescent prefer? Arch Pediatr Adolesc Med 2002; 156:588-591.
13. Eckert LO, Suchland RJ, Hawes SE, Stamm WE. Quantitative Chlamydia trachomatis cultures: Correlation of chlamydial inclusion forming units with serovar, age, gender, and race. J Infect Dis 2000; 182:540-544.
14. Morrison CS, Bright P, Wong EL, et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 2004; 31:561-567.
15. Jacobson DL, Peralta L, Farmer M, et al. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 2000; 27:313-319.
16. Dayan L, Donovan B. Chlamydia, gonorrhoea, and injectable progesterone. Lancet 2004; 364:1387-1388.